Drugs · acquisition-cost intelligence
sulfamethoxazole and trimethoprim
· ingredient sulfamethoxazoleCombinations of sulfonamides and trimethoprim, incl. derivatives· SULFAMETHOXAZOLE 200 mg/5mL; TRIMETHOPRIM 40 mg/5mL; SULFAMETHOXAZOLE 800 mg/20mL; TRIMETHOPRIM 160 mg/20mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.05660
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sulfamethoxazole products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Bactrim | $0.04286 | −$0.01370 |
| Sulfamethoxazole and Trimethoprim DS | $0.04619 | −$0.01040 |
| SULFATRIM | $0.05660 | +$0.00000 |
Medicare Part D coverage · CY2026
On 327 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.